Related references
Note: Only part of the references are listed.Early recognition of poor prognosis in Guillain-Barre syndrome
C. Walgaard et al.
NEUROLOGY (2011)
Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Norman Latov et al.
ARCHIVES OF NEUROLOGY (2010)
IVIG Treatment and Prognosis in Guillain-Barr, Syndrome
Pieter A. van Doorn et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy
K. Kuitwaard et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome A prospective study
L. Ruts et al.
NEUROLOGY (2010)
Pharmacokinetics of Intravenous Immunoglobulin and Outcome in Guillain-Barre Syndrome
Krista Kuitwaard et al.
ANNALS OF NEUROLOGY (2009)
Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome
Pieter A. van Doorn et al.
LANCET NEUROLOGY (2008)
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Richard A. C. Hughes et al.
LANCET NEUROLOGY (2008)
Immunotherapy for Guillain-Barre syndrome:: a systematic review
Richard A. C. Hughes et al.
BRAIN (2007)
A clinical prognostic scoring system for Guillain-Barre syndrome
Rinske van Koningsveld et al.
LANCET NEUROLOGY (2007)
Treatment of Guillain-Barre syndrome and CIDP
PA van Doorn
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2005)
Share Paper
